Cargando…

Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited

SIMPLE SUMMARY: Human papillomavirus positive tonsillar and base of tongue cancers are rising in incidence but chemoradiotherapy has not improved survival, so novel treatments are needed. Therefore, targeted therapy with phosphoinositide 3-kinase, poly-ADP-ribose-polymerase, and WEE1 inhibitors was...

Descripción completa

Detalles Bibliográficos
Autores principales: Byskata, Karin, Lukoseviciute, Monika, Tuti, Filippo, Zupancic, Mark, Kostopoulou, Ourania N., Holzhauser, Stefan, Dalianis, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818008/
https://www.ncbi.nlm.nih.gov/pubmed/36612094
http://dx.doi.org/10.3390/cancers15010093
_version_ 1784864879824338944
author Byskata, Karin
Lukoseviciute, Monika
Tuti, Filippo
Zupancic, Mark
Kostopoulou, Ourania N.
Holzhauser, Stefan
Dalianis, Tina
author_facet Byskata, Karin
Lukoseviciute, Monika
Tuti, Filippo
Zupancic, Mark
Kostopoulou, Ourania N.
Holzhauser, Stefan
Dalianis, Tina
author_sort Byskata, Karin
collection PubMed
description SIMPLE SUMMARY: Human papillomavirus positive tonsillar and base of tongue cancers are rising in incidence but chemoradiotherapy has not improved survival, so novel treatments are needed. Therefore, targeted therapy with phosphoinositide 3-kinase, poly-ADP-ribose-polymerase, and WEE1 inhibitors was pursued alone or combined with/without radiotherapy or using APR-246 and their effects were analyzed by WST-1 viability, proliferation, and cytotoxicity assays on tonsillar and base of tongue cancer cell lines. All three inhibitors induced dose dependent inhibition of viability and proliferation and their effects were enhanced by adding irradiation or by combining the inhibitors. However, adding irradiation to already synergistic inhibitor combinations did generally not induce additional inhibitory effects. Only very high APR-246 doses decreased viability, so its use was limited in this context. To conclude, the effects of the inhibitors were frequently enhanced by adding radiotherapy or by combining them, but adding radiotherapy to the latter did not generally induce further inhibition. ABSTRACT: Human papillomavirus positive (HPV(+)) tonsillar and base of tongue cancer (TSCC/BOTSCC) is rising in incidence, but chemoradiotherapy is not curative for all. Therefore, targeted therapy with PI3K (BYL719), PARP (BMN-673), and WEE1 (MK-1775) inhibitors alone or combined was pursued with or without 10 Gy and their effects were analyzed by viability, proliferation, and cytotoxicity assays on the TSCC/BOTSCC cell lines HPV(+) UPCI-SCC-154 and HPV(−) UT-SCC-60A. Effective single drug/10 Gy combinations were validated on additional TSCC lines. Finally, APR-246 was assessed on several TSCC/BOTSCC cell lines. BYL719, BMN-673, and MK-1775 treatments induced dose dependent responses in HPV(+) UPCI-SCC-154 and HPV(−) UT-SCC-60A and when combined with 10 Gy, synergistic effects were disclosed, as was also the case upon validation. Using BYL719/BMN-673, BYL719/MK-1775, or BMN-673/MK-1775 combinations on HPV(+) UPCI-SCC-154 and HPV(−) UT-SCC-60A also induced synergy compared to single drug administrations, but adding 10 Gy to these synergistic drug combinations had no further major effects. Low APR-246 concentrations had limited usefulness. To conclude, synergistic effects were disclosed when complementing single BYL719 BMN-673 and MK-1775 administrations with 10 Gy or when combining the inhibitors, while adding 10 Gy to the latter did not further enhance their already additive/synergistic effects. APR-246 was suboptimal in the present context.
format Online
Article
Text
id pubmed-9818008
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98180082023-01-07 Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited Byskata, Karin Lukoseviciute, Monika Tuti, Filippo Zupancic, Mark Kostopoulou, Ourania N. Holzhauser, Stefan Dalianis, Tina Cancers (Basel) Article SIMPLE SUMMARY: Human papillomavirus positive tonsillar and base of tongue cancers are rising in incidence but chemoradiotherapy has not improved survival, so novel treatments are needed. Therefore, targeted therapy with phosphoinositide 3-kinase, poly-ADP-ribose-polymerase, and WEE1 inhibitors was pursued alone or combined with/without radiotherapy or using APR-246 and their effects were analyzed by WST-1 viability, proliferation, and cytotoxicity assays on tonsillar and base of tongue cancer cell lines. All three inhibitors induced dose dependent inhibition of viability and proliferation and their effects were enhanced by adding irradiation or by combining the inhibitors. However, adding irradiation to already synergistic inhibitor combinations did generally not induce additional inhibitory effects. Only very high APR-246 doses decreased viability, so its use was limited in this context. To conclude, the effects of the inhibitors were frequently enhanced by adding radiotherapy or by combining them, but adding radiotherapy to the latter did not generally induce further inhibition. ABSTRACT: Human papillomavirus positive (HPV(+)) tonsillar and base of tongue cancer (TSCC/BOTSCC) is rising in incidence, but chemoradiotherapy is not curative for all. Therefore, targeted therapy with PI3K (BYL719), PARP (BMN-673), and WEE1 (MK-1775) inhibitors alone or combined was pursued with or without 10 Gy and their effects were analyzed by viability, proliferation, and cytotoxicity assays on the TSCC/BOTSCC cell lines HPV(+) UPCI-SCC-154 and HPV(−) UT-SCC-60A. Effective single drug/10 Gy combinations were validated on additional TSCC lines. Finally, APR-246 was assessed on several TSCC/BOTSCC cell lines. BYL719, BMN-673, and MK-1775 treatments induced dose dependent responses in HPV(+) UPCI-SCC-154 and HPV(−) UT-SCC-60A and when combined with 10 Gy, synergistic effects were disclosed, as was also the case upon validation. Using BYL719/BMN-673, BYL719/MK-1775, or BMN-673/MK-1775 combinations on HPV(+) UPCI-SCC-154 and HPV(−) UT-SCC-60A also induced synergy compared to single drug administrations, but adding 10 Gy to these synergistic drug combinations had no further major effects. Low APR-246 concentrations had limited usefulness. To conclude, synergistic effects were disclosed when complementing single BYL719 BMN-673 and MK-1775 administrations with 10 Gy or when combining the inhibitors, while adding 10 Gy to the latter did not further enhance their already additive/synergistic effects. APR-246 was suboptimal in the present context. MDPI 2022-12-23 /pmc/articles/PMC9818008/ /pubmed/36612094 http://dx.doi.org/10.3390/cancers15010093 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Byskata, Karin
Lukoseviciute, Monika
Tuti, Filippo
Zupancic, Mark
Kostopoulou, Ourania N.
Holzhauser, Stefan
Dalianis, Tina
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
title Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
title_full Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
title_fullStr Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
title_full_unstemmed Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
title_short Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
title_sort targeted therapy with pi3k, parp, and wee1 inhibitors and radiotherapy in hpv positive and negative tonsillar squamous cell carcinoma cell lines reveals synergy while effects with apr-246 are limited
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818008/
https://www.ncbi.nlm.nih.gov/pubmed/36612094
http://dx.doi.org/10.3390/cancers15010093
work_keys_str_mv AT byskatakarin targetedtherapywithpi3kparpandwee1inhibitorsandradiotherapyinhpvpositiveandnegativetonsillarsquamouscellcarcinomacelllinesrevealssynergywhileeffectswithapr246arelimited
AT lukoseviciutemonika targetedtherapywithpi3kparpandwee1inhibitorsandradiotherapyinhpvpositiveandnegativetonsillarsquamouscellcarcinomacelllinesrevealssynergywhileeffectswithapr246arelimited
AT tutifilippo targetedtherapywithpi3kparpandwee1inhibitorsandradiotherapyinhpvpositiveandnegativetonsillarsquamouscellcarcinomacelllinesrevealssynergywhileeffectswithapr246arelimited
AT zupancicmark targetedtherapywithpi3kparpandwee1inhibitorsandradiotherapyinhpvpositiveandnegativetonsillarsquamouscellcarcinomacelllinesrevealssynergywhileeffectswithapr246arelimited
AT kostopoulououranian targetedtherapywithpi3kparpandwee1inhibitorsandradiotherapyinhpvpositiveandnegativetonsillarsquamouscellcarcinomacelllinesrevealssynergywhileeffectswithapr246arelimited
AT holzhauserstefan targetedtherapywithpi3kparpandwee1inhibitorsandradiotherapyinhpvpositiveandnegativetonsillarsquamouscellcarcinomacelllinesrevealssynergywhileeffectswithapr246arelimited
AT dalianistina targetedtherapywithpi3kparpandwee1inhibitorsandradiotherapyinhpvpositiveandnegativetonsillarsquamouscellcarcinomacelllinesrevealssynergywhileeffectswithapr246arelimited